Company Info
| Phone: | (484) 581-7505 |
| Year Established: | 2004 |
| Ticker: | ZYNE |
| Exchange: | NASDAQ |
Contacts
| Primary: | Jim Fickenscher CFO & VP, Corporate Development |
| Other: | Armando Anido Chair & CEO Terri B. Sebree President Donna L. Gutterman, PharmD VP, Medical Albert P. Parker CLO Ray Mannion VP, Manufacturing |
Company Description
Zynerba Pharmaceuticals is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.
